Construction of a novel cuproptosis-related gene signature and integrative analyses in cholangiocarcinoma

Background: Cuproptosis is a unique form of cell death that is dependent on copper, which is fundamentally different from other recognized forms of cell death. However, the molecular and immune characteristics in cuproptosis-defined subgroups of cholangiocarcinoma (CCA) remain to be further illustra...

Full description

Saved in:
Bibliographic Details
Main Authors: Liye Wang, Pan Li, Shuai Gong, Lina Pang, Mingyu Li, Chi Zhang, Shengli Zhang, Xiaoke Zhang, Guozhong Jiang, Wei He
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844024176311
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841533296494772224
author Liye Wang
Pan Li
Shuai Gong
Lina Pang
Mingyu Li
Chi Zhang
Shengli Zhang
Xiaoke Zhang
Guozhong Jiang
Wei He
author_facet Liye Wang
Pan Li
Shuai Gong
Lina Pang
Mingyu Li
Chi Zhang
Shengli Zhang
Xiaoke Zhang
Guozhong Jiang
Wei He
author_sort Liye Wang
collection DOAJ
description Background: Cuproptosis is a unique form of cell death that is dependent on copper, which is fundamentally different from other recognized forms of cell death. However, the molecular and immune characteristics in cuproptosis-defined subgroups of cholangiocarcinoma (CCA) remain to be further illustrated. Methods: We conducted a comprehensive investigation into the genetic and transcriptional variation, prognostic significance, and expression profiles of 16 cuproptosis-related genes (CRGs). To construct a prognostic signature based on differentially expressed genes between molecular subtypes, we employed LASSO and multivariate Cox regression analyses. We then assessed the values of this signature in prognostic prediction, immune infiltration, and therapeutic responses in CCA. The robustness of the signature was further validated in the GEO and IMvigor210 cohorts. Additionally, qRT-PCR and Western blotting (WB) were utilized to confirm the expression of the signature genes across different cell lines. Results: A total of 16 CRGs were analyzed revealed differentially expressed, and two CRG-related clusters were identified, which displayed contrasting survival times.Then, a robust cuproptosis-related risk model was established and was an independent prognostic factor for CCA, which was further validated across two external cohorts. Low-risk patients had a better overall survival than high-risk patients. The comprehensive results showed that a low-risk score was correlated with metabolism-related pathways, high infiltration of CD8 T cells, B cells, and M1 macrophages, active immunity and less aggressive phenotypes, high chemotherapeutic sensitivity, and more benefit from immunotherapy. In contrast, a high-risk score was associated with cancer and metastasis-related pathways, high infiltration of M2 macrophages, high expression of immune checkpoint genes, suppressive immunity and more aggressive phenotypes, and less benefit from chemotherapeutic and immunotherapy. In addition, the critical CRGs were further validated through qRT-PCR and WB. Conclusions: We developed a novel risk model for CCA patients, which serves as a promising biomarker for distinguishing prognosis as well as molecular and immune characteristics.
format Article
id doaj-art-410dfaf2ddf74831be9ce6aa09cf50dd
institution Kabale University
issn 2405-8440
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj-art-410dfaf2ddf74831be9ce6aa09cf50dd2025-01-17T04:51:44ZengElsevierHeliyon2405-84402025-01-01111e41600Construction of a novel cuproptosis-related gene signature and integrative analyses in cholangiocarcinomaLiye Wang0Pan Li1Shuai Gong2Lina Pang3Mingyu Li4Chi Zhang5Shengli Zhang6Xiaoke Zhang7Guozhong Jiang8Wei He9Department of Oncology, The First Affiliated Hospital of Zhengzhou University, No.1 Eastern Jianshe Road, Zhengzhou, 450052, Henan, ChinaDepartment of Pathology, The First Affiliated Hospital of Zhengzhou University, No.1 Eastern Jianshe Road, Zhengzhou, 450052, Henan, ChinaDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, No.1 Eastern Jianshe Road, Zhengzhou, 450052, Henan, ChinaDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, No.1 Eastern Jianshe Road, Zhengzhou, 450052, Henan, ChinaDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, No.1 Eastern Jianshe Road, Zhengzhou, 450052, Henan, ChinaDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, No.1 Eastern Jianshe Road, Zhengzhou, 450052, Henan, ChinaDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, No.1 Eastern Jianshe Road, Zhengzhou, 450052, Henan, ChinaDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, No.1 Eastern Jianshe Road, Zhengzhou, 450052, Henan, ChinaDepartment of Pathology, The First Affiliated Hospital of Zhengzhou University, No.1 Eastern Jianshe Road, Zhengzhou, 450052, Henan, ChinaDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, No.1 Eastern Jianshe Road, Zhengzhou, 450052, Henan, China; Corresponding author. The First Affiliated Hospital of Zhengzhou University No.1 Eastern Jianshe Road Zhengzhou, 450052, Henan, China.Background: Cuproptosis is a unique form of cell death that is dependent on copper, which is fundamentally different from other recognized forms of cell death. However, the molecular and immune characteristics in cuproptosis-defined subgroups of cholangiocarcinoma (CCA) remain to be further illustrated. Methods: We conducted a comprehensive investigation into the genetic and transcriptional variation, prognostic significance, and expression profiles of 16 cuproptosis-related genes (CRGs). To construct a prognostic signature based on differentially expressed genes between molecular subtypes, we employed LASSO and multivariate Cox regression analyses. We then assessed the values of this signature in prognostic prediction, immune infiltration, and therapeutic responses in CCA. The robustness of the signature was further validated in the GEO and IMvigor210 cohorts. Additionally, qRT-PCR and Western blotting (WB) were utilized to confirm the expression of the signature genes across different cell lines. Results: A total of 16 CRGs were analyzed revealed differentially expressed, and two CRG-related clusters were identified, which displayed contrasting survival times.Then, a robust cuproptosis-related risk model was established and was an independent prognostic factor for CCA, which was further validated across two external cohorts. Low-risk patients had a better overall survival than high-risk patients. The comprehensive results showed that a low-risk score was correlated with metabolism-related pathways, high infiltration of CD8 T cells, B cells, and M1 macrophages, active immunity and less aggressive phenotypes, high chemotherapeutic sensitivity, and more benefit from immunotherapy. In contrast, a high-risk score was associated with cancer and metastasis-related pathways, high infiltration of M2 macrophages, high expression of immune checkpoint genes, suppressive immunity and more aggressive phenotypes, and less benefit from chemotherapeutic and immunotherapy. In addition, the critical CRGs were further validated through qRT-PCR and WB. Conclusions: We developed a novel risk model for CCA patients, which serves as a promising biomarker for distinguishing prognosis as well as molecular and immune characteristics.http://www.sciencedirect.com/science/article/pii/S2405844024176311CuproptosisCholangiocarcinomaMolecular subtypesPrognostic modelTumor microenvironmentDrug sensitivity
spellingShingle Liye Wang
Pan Li
Shuai Gong
Lina Pang
Mingyu Li
Chi Zhang
Shengli Zhang
Xiaoke Zhang
Guozhong Jiang
Wei He
Construction of a novel cuproptosis-related gene signature and integrative analyses in cholangiocarcinoma
Heliyon
Cuproptosis
Cholangiocarcinoma
Molecular subtypes
Prognostic model
Tumor microenvironment
Drug sensitivity
title Construction of a novel cuproptosis-related gene signature and integrative analyses in cholangiocarcinoma
title_full Construction of a novel cuproptosis-related gene signature and integrative analyses in cholangiocarcinoma
title_fullStr Construction of a novel cuproptosis-related gene signature and integrative analyses in cholangiocarcinoma
title_full_unstemmed Construction of a novel cuproptosis-related gene signature and integrative analyses in cholangiocarcinoma
title_short Construction of a novel cuproptosis-related gene signature and integrative analyses in cholangiocarcinoma
title_sort construction of a novel cuproptosis related gene signature and integrative analyses in cholangiocarcinoma
topic Cuproptosis
Cholangiocarcinoma
Molecular subtypes
Prognostic model
Tumor microenvironment
Drug sensitivity
url http://www.sciencedirect.com/science/article/pii/S2405844024176311
work_keys_str_mv AT liyewang constructionofanovelcuproptosisrelatedgenesignatureandintegrativeanalysesincholangiocarcinoma
AT panli constructionofanovelcuproptosisrelatedgenesignatureandintegrativeanalysesincholangiocarcinoma
AT shuaigong constructionofanovelcuproptosisrelatedgenesignatureandintegrativeanalysesincholangiocarcinoma
AT linapang constructionofanovelcuproptosisrelatedgenesignatureandintegrativeanalysesincholangiocarcinoma
AT mingyuli constructionofanovelcuproptosisrelatedgenesignatureandintegrativeanalysesincholangiocarcinoma
AT chizhang constructionofanovelcuproptosisrelatedgenesignatureandintegrativeanalysesincholangiocarcinoma
AT shenglizhang constructionofanovelcuproptosisrelatedgenesignatureandintegrativeanalysesincholangiocarcinoma
AT xiaokezhang constructionofanovelcuproptosisrelatedgenesignatureandintegrativeanalysesincholangiocarcinoma
AT guozhongjiang constructionofanovelcuproptosisrelatedgenesignatureandintegrativeanalysesincholangiocarcinoma
AT weihe constructionofanovelcuproptosisrelatedgenesignatureandintegrativeanalysesincholangiocarcinoma